CRSP
CRISPR Therapeutics AG · Healthcare
CEO Samarth Kulkarni sold $507K of CRISPR Therapeutics AG
Sold$507,498
$79.67Price
6,370Shares
−2%Stake
What CRSP did after the filing
- The stock from Wed, Feb 21 close, $82.41
- −21.1%
- S&P 500, same days
- +3.5%
Measured over 30 trading days, to the Apr 4 close.
Traded Tue, Feb 20. Filed Wed, Feb 21, 12:45 PM ET, during the session. Returns use the Feb 21 close and the Apr 4 close. Not investment advice.